Jenoptik AG

  • WKN: A2NB60
  • ISIN: DE000A2NB601
  • Land: Germany

Nachricht vom 25.11.2021 | 07:07

JENOPTIK AG: JENOPTIK AG signs agreement to sell VINCORION

JENOPTIK AG / Key word(s): Disposal
JENOPTIK AG: JENOPTIK AG signs agreement to sell VINCORION

25-Nov-2021 / 07:07 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


JENOPTIK AG signs agreement to sell VINCORION

JENOPTIK AG (FSE: JEN / ISIN: DE000A2NB601) has signed an agreement to sell the VINCORION division. It will be acquired by a fund managed by STAR Capital Partnership LLP ("STAR"). STAR is a leading private equity firm investing in medium-sized companies across Europe. VINCORION develops, produces, and sells mechatronic products in particular for the defense and security sector, the aviation as well as the rail and transportation industries.

The equity value is in the mid double-digit million euro range. In addition, there are claims and obligations (e.g. resulting from pension obligations) in the mid double-digit million euro range as well as certain earn-out components. The enterprise value amounts to approximately 130 million euros. Both parties have agreed not to disclose any further details.

Closing of the purchase agreement is still subject to approval by the responsible authorities and other customary closing conditions. Closing is expected to take place in the second half of 2022.

Due to the signing of the agreement to sell VINCORION the division will be classified as "discontinued operations" already in the current fiscal year. In total, there will be no change to the guidance 2021 when both, continuing operations and discontinued operations, are taken into account.

If you have any further questions, please contact:
JENOPTIK AG | Investor Relations & Corporate Communications
Leslie Iltgen
Vice President Investor Relations & Communications
Phone: +49 3641 65-2291
E-Mail: leslie.iltgen@jenoptik.com

Sabine Barnekow
Investor Relations Manager
Phone: +49 3641 65-2156
E-Mail: sabine.barnekow@jenoptik.com


Forward-looking statements
This announcement can contain forward-looking statements that are based on current expectations and certain assumptions of the management of the Jenoptik Group. A variety of known and unknown risks, uncertainties and other factors can cause the actual results, the financial situation, the development or the performance of the company to be materially different from the announced forward-looking statements. Such factors can be, among others, pandemic diseases, changes in currency exchange rates and interest rates, the introduction of competing products or the change of the business strategy. The company does not assume any obligation to update such forward-looking statements in the light of future developments.




Contact:
Leslie Iltgen
Vice President Investor Relations & Communications
Phone 03641-652291

25-Nov-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021